From Technology Review:
Fragments of known drugs could lead to a more robust antiviral for H1N1 and other flu variants.
The flu virus is a wily target, constantly mutating to avoid attack from the immune system and from antiviral drugs like Tamiflu. But in research presented Sunday at the annual meeting of the American Society for Cell Biology (ASCB) in San Diego, scientists announced a new method for fighting pandemic influenzas such as H1N1 (swine) and H5N1 (avian).
Read more ....
No comments:
Post a Comment